Analyst consensus rating
P3 Health Partners Analyst Rating: Buy
PIII is rated Buy by 2 analysts with a $18.00 target. As of 2026-08-31.
Direct answer
P3 Health Partners's consensus rating is Buy.
2 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $18.00.
Forecast evidence checked August 31, 2026.
Get free P3 Health Partners email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $9.06
- Average price target
- $18.00
- High price target
- $23.00
- Low price target
- $13.00
- Low target gap
- +43.5%
- Target upside
- +98.7%
- High target gap
- +153.9%
- Target range width
- 110.4%
- Consensus rating
- Buy
- Analysts
- 2
- Evidence date
- August 31, 2026
- Valid through
- September 7, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for P3 Health Partners?
P3 Health Partners has a verified Buy consensus. The same dataset has an average price target of $18.00.
How far are P3 Health Partners's low and high targets from the recorded price?
The low target implies +43.5%, while the high target implies +153.9%.
How many analysts are included in P3 Health Partners's consensus?
The verified consensus includes 2 analysts.
How is P3 Health Partners's target upside or downside calculated?
The average target of $18.00 is divided by the recorded price of $9.06, then one is subtracted to produce +98.7%. This does not guarantee a future return.
When was P3 Health Partners's analyst forecast verified?
The data was verified on 2026-08-31. The dataset is valid through 2026-09-07.